HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nicholas A Moore Selected Research

Spasm (Spasms)

1/2017Surgical approach to limiting skin contracture following protractor myectomy for essential blepharospasm.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nicholas A Moore Research Topics

Disease

4Weight Gain
09/2006 - 05/2003
3Hyperphagia (Overeating)
09/2006 - 05/2003
2Macular Degeneration (Age-Related Maculopathy)
10/2017 - 01/2017
1Carcinoid Tumor (Carcinoid)
01/2020
1Irritable Bowel Syndrome (Syndrome, Irritable Bowel)
01/2020
1Vomiting
01/2020
1Diarrhea
01/2020
1Optic Nerve Diseases (Optic Neuropathy)
05/2018
1Glaucoma
05/2018
1Ocular Hypertension (Glaucoma, Suspect)
05/2018
1Pruritus (Itching)
12/2017
1Erythema
12/2017
1Hypersensitivity (Allergy)
12/2017
1Allergic Contact Dermatitis
12/2017
1Geographic Atrophy
10/2017
1Spasm (Spasms)
01/2017
1Benign essential blepharospasm
01/2017
1Disease Progression
01/2017
1Contracture
01/2017
1Open-Angle Glaucoma (Glaucoma, Open Angle)
01/2016
1Obesity
01/2014
1Constipation
01/2013
1Abdominal Pain (Pain, Abdominal)
01/2013
1Mania (Manias)
12/2005
1Schizophrenia (Dementia Praecox)
12/2005
1Serotonin Syndrome (Syndrome, Serotonin)
01/2002

Drug/Important Bio-Agent (IBA)

3Serotonin (5 Hydroxytryptamine)IBA
01/2020 - 01/2002
3Retinaldehyde (Retinal)IBA
05/2018 - 01/2016
3Antipsychotic Agents (Antipsychotics)IBA
09/2006 - 05/2003
2alosetron (Lotronex)FDA Link
01/2020 - 01/2013
2Pharmaceutical PreparationsIBA
01/2020 - 09/2006
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2018 - 10/2017
2Olanzapine (Zyprexa)FDA Link
09/2006 - 05/2003
2phospholipid emulsion soybean oil (Intralipid)IBA
09/2006 - 09/2003
15-HT3 Serotonin Receptors (5 HT3 Receptor)IBA
01/2020
1Endothelial Growth FactorsIBA
05/2018
1Dexamethasone (Maxidex)FDA LinkGeneric
12/2017
1NeomycinFDA LinkGeneric
12/2017
1Ointments (Pastes)IBA
12/2017
1Polymyxin B (Aerosporin)FDA LinkGeneric
12/2017
1neodymium pyrocatechin disulfonate (NPD)IBA
12/2017
1Proteins (Proteins, Gene)FDA Link
10/2017
1Complement System Proteins (Complement)IBA
10/2017
1Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2017
1CytokinesIBA
01/2017
1Botulinum Toxins (Botulinum Toxin)IBA
01/2017
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2017
1ALB-127158(a)IBA
01/2014
1Ion Channels (Ion Channel)IBA
01/2013
1Cocaine (Cocaine HCl)IBA
09/2006
1Dopamine (Intropin)FDA LinkGeneric
09/2006
1Dopamine AntagonistsIBA
09/2006
1Quetiapine Fumarate (Seroquel)FDA Link
09/2006
1ProlactinIBA
12/2005
1Pyrilamine (Mepyramine)FDA Link
09/2003
1EmulsionsIBA
09/2003
1Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA
09/2003
15-HT2C Serotonin ReceptorIBA
09/2003
1MetergolineIBA
09/2003
1Histamine H1 Receptors (Histamine H1 Receptor)IBA
09/2003
16- chloro- 5- methyl- 1- ((2- (2- methylpyrid- 3- yloxy)pyrid- 5- yl)carbamoyl)indolineIBA
09/2003
1Histamine (Histamine Dihydrochloride)FDA Link
09/2003
1Cyproheptadine (Periactin)FDA Link
09/2003
1Haloperidol (Haldol)FDA LinkGeneric
05/2003
1Clozapine (Clozaril)FDA LinkGeneric
05/2003
1ApomorphineFDA Link
01/2002

Therapy/Procedure

3Therapeutics
05/2018 - 01/2017
2Injections
05/2018 - 01/2017
1Oral Administration
01/2020
1Intravitreal Injections
05/2018
1Sutures (Suture)
01/2017